Drug repurposing: a better approach for infectious disease drug discovery?
about
Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusBenchmarking selected computational gene network growing tools in context of virus-host interactions.Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates.Identification of Nitazoxanide as a Group I Metabotropic Glutamate Receptor Negative Modulator for the Treatment of Neuropathic Pain: An In Silico Drug Repositioning Study.New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant BacteriaThe Oral Antimalarial Drug Tafenoquine Shows Activity against Trypanosoma brucei.The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasisInhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses.Computational Drug Target Screening through Protein Interaction Profiles.Antivirulence activity of azithromycin in Pseudomonas aeruginosaComputational modeling of the bat HKU4 coronavirus 3CL(pro) inhibitors as a tool for the development of antivirals against the emerging Middle East respiratory syndrome (MERS) coronavirus.Identification of Potential Therapeutics to Conquer Drug Resistance in Salmonella typhimurium: Drug Repurposing Strategy.Interferon regulated gene (IRG) expression-signature in a mouse model of chikungunya virus neurovirulence.Drug repurposing: An approach to tackle drug resistance in S. typhimurium.A systematic and prospectively validated approach for identifying synergistic drug combinations against malaria.
P2860
Q28076034-4A093BB2-CE3B-43B9-9ECC-563E26B710E0Q28084005-CE55AF3F-61CE-4662-A30A-AA0D3FAB349AQ33918669-A08B5C49-3829-4E43-80F7-2A8EDFC1F7E7Q35532814-0BC0478D-660B-4351-8D33-7A614C34BE89Q35575400-C2ECDCAA-A31D-4DE7-8615-118F67318D6EQ35986316-948A7360-A1BE-4707-99E5-B497356ABB26Q36076081-0A1CDF19-DD9D-49AC-8981-1FCF5C9D326CQ36932080-354911BA-6051-4D80-94E1-3CB8DBEB39DCQ37347305-85B5F563-78EA-4C69-AC3A-CC4A0A509958Q37414273-4A1EA424-C586-492C-B0F3-4CEDEB103D0CQ38209321-7E6C7FAE-F381-4E8E-902B-1EF4DC5A04E1Q38728233-0E41DBA6-5692-41FE-98C1-9C51DDD31D68Q39268520-3B094B07-DEFF-490B-BBE1-D67D0A75CB18Q44843636-910C54A2-D84D-4A25-AF2E-618E64DB881BQ48146177-F4E71F82-1A42-4D19-BDE4-8BE80B64BA6DQ52593425-CFD05C77-6B1A-4A9C-B168-D3C1367721C5
P2860
Drug repurposing: a better approach for infectious disease drug discovery?
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Drug repurposing: a better approach for infectious disease drug discovery?
@ast
Drug repurposing: a better approach for infectious disease drug discovery?
@en
Drug repurposing: a better approach for infectious disease drug discovery?
@nl
type
label
Drug repurposing: a better approach for infectious disease drug discovery?
@ast
Drug repurposing: a better approach for infectious disease drug discovery?
@en
Drug repurposing: a better approach for infectious disease drug discovery?
@nl
prefLabel
Drug repurposing: a better approach for infectious disease drug discovery?
@ast
Drug repurposing: a better approach for infectious disease drug discovery?
@en
Drug repurposing: a better approach for infectious disease drug discovery?
@nl
P2093
P2860
P1476
Drug repurposing: a better approach for infectious disease drug discovery?
@en
P2093
G Lynn Law
Jennifer Tisoncik-Go
Marcus J Korth
P2860
P304
P356
10.1016/J.COI.2013.08.004
P577
2013-09-05T00:00:00Z